人工脏器

中空纤维分离膜在人工脏器中的应用

Research of membrane in application to new artificial organs

用于制造人工脏器的高分子材料

The Polymer Materials Used in Making Artificial Organs

膜技术在人工脏器上的应用与展望

Application and Expectation of Membrane Technology about Artificial Viscera

新型膜式人工脏器的研究进展

Research Progress of New Artificial Organs Used Membrane

后写了由这些问题使我们意识人工脏器技术发展是有禁区的，这个禁区是伦理为它确立的限度。

Then it has realized ethical limits in the development process of the artificial organ .

然而，人工脏器和医用装置直接或间接诱发人体血栓形成的问题至今仍未彻底解决。

Nevertheless , the problem of thrombosis caused by artificial organs and medical devices still remains by now .

作为现代医疗技术之一的人工脏器技术一旦研究成功，都将以最快的速度进入公众生活，直接影响他们的生活。

If an artificial organ technology , once studies successfully , it will enter the public life at the quickest speed and immediately affect their life .

介绍了膜技术在生物医学上的一些应用，包括：生物大分子的膜分离、高分子膜人工脏器、膜生物反应器、生物微胶囊，以及膜探感器五个方面。

The applications of membrane technology in biomedicine were reviewed in the following five fields : separation of biomoleculars , bioartificial organs , membrane bioreactors , microcapsules , and biosensors .

接着在前人的基础上写人工脏器技术在发展的过程中应遵循的四个伦理原则：尊重生命原则、不伤害原则、利益原则和公正原则。

Four ethical principles should be followed in the development process : the principle of respect for life , not to harm principle , the principle of interests and the principles of justice .

最后则是针对人工脏器技术伦理问题提出了相应的解决对策：构建新的人文精神；强化人的道德理性；转变社会观念；健全法律规范。

Finally it proposed four solutions for ethical issues . It should be constructed the new humane spirit , strengthen the moral reason , changed public original manner , and perfected relevant laws and regulations .

由此可见，人工脏器和医用装置的研究和开发已经成为推动现代医学科技进步的重要动力，而且也很可能成为21世纪重要的支柱产业之一。

We can expect that investigation and invention of new artificial organs and medical devices will become the important power to impel the development of medical sciences and techniques . And it will be possibly to be one of the important support industry in the coming century .

对人工感染病死兔脏器含毒量的检测，肝、脾含毒量最高，HA可达29；

The virus contents of liver and spleen were the highest with HA titer 2 9 ;